REGISTERED NUMBER: 08395526 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 March 2025

for

Ultra Fast Hormones Ltd

Page

Balance Sheet

1

FIXED ASSETS

1,262

1,885

CURRENT ASSETS

274,307

235,360

CREDITORS

Amounts falling due within one year

(21,274

)

(42,371

)

NET CURRENT ASSETS

253,033

192,989

TOTAL ASSETS LESS CURRENT LIABILITIES

254,295

194,874

CAPITAL AND RESERVES

254,295

194,874

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

Ultra Fast Hormones Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

08395526

Registered office:

Second Floor, Kirkland House

11-15 Peterborough Road

Harrow

Middlesex

HA1 2AX

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2024 - 2 ) .

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 10 December 2025 and were signed on its behalf by:

T R Kurzawinski - Director